Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Clinch

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Autism : the International Journal of Research and Practice|June 25, 2025
Development of a Goal Attainment Scale (GAS) outcome measure for clinical interventional studies in paediatric autismHannah Staunton, Tammy McIver, Julian Tillmann, et al.
Annals of Clinical and Translational Neurology|October 26, 2024
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I studyScott D Newsome, Lawrence Goldstick, Derrick S Robertson, et al.
Neurology|April 17, 2025
Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II StudyScott D Newsome, Ewa Krzystanek, Krzysztof W Selmaj, et al.
Neurology|December 3, 2024
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label TrialHans-Peter Hartung, Ralph H B Benedict, Thomas Berger, et al.
Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Autism : the International Journal of Research and Practice|June 25, 2025
Development of a Goal Attainment Scale (GAS) outcome measure for clinical interventional studies in paediatric autismHannah Staunton, Tammy McIver, Julian Tillmann, et al.
Annals of Clinical and Translational Neurology|October 26, 2024
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I studyScott D Newsome, Lawrence Goldstick, Derrick S Robertson, et al.
Neurology|April 17, 2025
Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II StudyScott D Newsome, Ewa Krzystanek, Krzysztof W Selmaj, et al.
Neurology|December 3, 2024
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label TrialHans-Peter Hartung, Ralph H B Benedict, Thomas Berger, et al.
Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.
Pageof 2